In which continent has the WHO granted approval for its first Mpox vaccine for adults?

A)
Africa
B)
Asia
C)
Europe
D)
South America

Correct Answer :   Africa


The World Health Organization (WHO) has recently granted approval for its first Mpox vaccine specifically for use in Africa.

This vaccine, developed by Bavarian Nordic A/S, represents a significant advancement in addressing Mpox, particularly in the African region.

The approval allows for the vaccine's pre-qualification for purchase by international donors such as GAVI and UNICEF.

Despite its limited supply due to a single manufacturer, this development is a critical step in controlling outbreaks and improving public health in Africa.

Published On : September 15, 2024